Distribution of radioiodinated recombinant human nerve growth factor in primate brain following intracerebroventricular infusion

Experimental Neurology

Volumn 140, Issue 2, 1996, Pages 151-160

  Emmett, Caroline J ^a   Stewart, Gregory R ^a,c   Johnson, Randolph M ^a   Aswani, Shakun P ^e   Chan, Rebecca L ^b   Jakeman, Lyn B ^a,d  

^a Neurobiology Unit   (United States)

^b ROCHE BIOSCIENCE   (United States)

^c ALZA CORPORATION   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE ACETYLTRANSFERASE; IODINE 125; RECOMBINANT NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BRAIN VENTRICLE; CHOLINERGIC NERVE CELL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MONKEY; NONHUMAN; PRIORITY JOURNAL;

EID: 0030222206     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.0125     Document Type: Article

References (53)

1. 1. ALTAR, C. A., L. E. BURTON, G. L. BENNETT, AND M. DUGICH-DJORDJEVIC. 1991. Recombinant human nerve growth factor is biologically active and labels novel high-affinity binding sites in rat brain. Proc. Natl. Acad. Sci. USA 88: 281-285.
2. 2. BARTUS, R. T., R. L. DEAN III, B. BEER, AND A. S. LIPPA. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408-117.
3. 3. DAVIDSON, I. W. F., J. C. PARKER, AND R. P. BELILES. 1986. Biological basis for extrapolation across mammalian species. Reg. Toxicol. Pharmacol. 6: 211-237.
4. 4. DISTEFANO, P. S., B. FRIEDMAN, C. RADZIEJEWSKI, C. ALEXANDER, P. BOLAND, C. M. SCHICCK, R. M. LINDSAY, AND S. J. WEIGAND. 1992. The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron 8: 983-993.
5. 5. EMMETT, C. J., S. P. ASWANI, G. R. STEWART, D. FAIRCHILD, AND R. M. JOHNMSON. 1995. Dose-response comparison of recombinant human nerve growth factor and recombinant human basic fibroblast growth factor in the fimbria-fornix model of acute cholinergic degeneration. Brain Res. 673: 199-207.
6. 6. EVERITT, H. J., T. E. SIRKIA, A. C. ROBERTS, G. H. JONES, AND T. W. ROBBINS. 1988. Distribution and some projections of cholinergic neurons in the brain of the common marmoset, Callithrix jacchus. J. Comp. Neurol. 271: 533-558.
7. 7. FERGUSON, I. A., J. B. SCHWIETZER, P. F. BARTLETT, AND E. M. JOHNSON JR. 1991. Receptor-mediated retrograde transport in CNS neurons after intraventricular administration of NGF and growth factors. J. Comp. Neurol. 313: 680-692.
8. 8. FISCHER, W., K. WICTORIN, A. BJORKLUND, L. R. WILLIAMS, S. VARON, AND F. H. GAGE. 1987. Amelioration of cholinergic neuronal atrophy and spatial memory impairment in aged rats by nerve growth factor. Nature 329: 65-68.
9. 9. FISCHER, W., A. BJORKLUND, K. CHEN, AND F. H. GAGE. 1991. NGF improves spatial memory in aged rodents as a function of age. J. Neurosci. 11: 1889-1906.
10. 10. FRIDEN, P. M., L. R. WALUS, P. WATSON, S. R. DOCTROW, J. W. KOZARICH, C. BACKMAN, H. BERGMAN, B. HOFFER, F. BLOOM, AND A. C. GRANHOLM. 1993. Blood-brain barrier penetration and in vivo activity of an NGF conjugate. Science 259: 373-377.
11. 11. GERGEN, J. A., AND P. D. MACLEAN. 1962. A Stereotaxic Atlas of the Squirrel Monkey's Brain (Saimiri sciureus). Public Health Service Publication No. 933. U.S. Department of Health, Education and Welfare.
12. 12. HANTZOPOULOS, P., C. SURI, D. J. GLASS, M. GOLDFARB, AND G. D. YANCOPOULOS. 1994. The low affinity NGF receptor, p75, can collaborate with each of the trks to potentiate functional responses to the neurotrophins. Neuron 13: 187-201.
13. 13. HEFTI, F., AND L. S. SCHNEIDER. 1991. Rationale for the planned clinical trials with nerve growth factor in Alzheimer's disease. Psych. Dev. 4: 297-315.
14. 14. HEFTI, F. 1986. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6: 2155-2162.
15. 15. HEFTI, F. 1994. Neurotrophic factor therapy for nervous system degenerative diseases. J. Neurobiol. 25: 1418-1435.
16. trk mRNA marks responsive forebrain neurons: Evidence that trk gene expression is induced by NGF. Neuron 9: 465-478.
17. 17. IP, N. Y., T. N. STITT, P. TAPLEY, R. KLEIN, D. J. GLASS, J. FANDL, L. A. GREENE, M. BARBACID, AND G. D. YANCOPOULOS. 1993. Similarities and differences in the way neurotrophins interact with the trk receptors in neuronal and non-neuronal cells. Neuron 9: 1067-1079.
18. 18. KAPLAN, D. R., D. MARTIN-ZANCA, AND L. PARADA. 1991. Tyrosine phosphorylation and tyrosine kinase activity of the trk proto-oncogene product induced by NGF. Nature 350: 158-160.
19. 19. KAPLAN, D. R., B. L. HEMPSTEAD, D. MARTIN-ZANCA, M. V. CHAO, AND L. PARADA. 1991. The trk proto-oncogene product: A signal-transducing receptor for nerve growth factor. Science 252: 554-558.
20. 20. KITT, C. A., S. J. MITCHELL, M. R. DELONG, B. H. WAINER, AND D. L. PRICE. 1987. Fiber pathways of basal forebrain cholinergic neurons in monkeys. Brain Res. 406: 192-206.
21. 21. KOLIATSOS, V. E., M. D. APPLEGATE, B. KNUSEL, E. O. JUNARD, L. E. BURTON, W. C. MOBLEY, F. HEFTI, AND D. L. PRICE. 1991. Recombinant human nerve growth factor prevents retrograde degeneration of axotomized basal forebrain cholinergic neurons in the rat. Exp. Neurol. 112: 161-173.
22. 22. KOLIATSOS, V. E., R. E. CLATTERBUCK, H. J. W. NAUTA, B. KNUSEL, L. E. BURTON, F. F. HEFTI, W. C. MOBLEY, AND D. L. PRICE. 1991. Human nerve growth factor prevents degeneration of basal forebrain cholinergic neurons in primates. Ann Neurol. 30: 831-840.
23. 23. KOLIATSOS, V. E., H. J. W. NAUTA, R. E. CLATTERBUCK, D. M. HOLTZMANN, AND W. E. MOBLEY. 1990. Mouse nerve growth factor prevents degeneration of axotomized basal forebrain cholinergic neurons in the monkey. J. Neurosci. 10: 3801-3813.
24. 24. KORDOWER, J. H., R. T. BARTUS, M. BOTHWELL, G. SCHATTEMAN, AND D. N. GASH. 1988. Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): Distribution, morphology, and colocalization with cholinergic enzymes. J. Comp. Neurol. 277: 465-486.
25. 125I] nerve growth factor in the rat brain following a single intraventricular injection: Correlation with the topographical distribution of trk A messenger RNA-expressing cells. Neuroscience 54: 445-460.
26. 26. LUX, JR., W. E. AND J. D. FENSTERMACHER. 1975. Cerebrospinal fluid formation in ventricles and spinal subarachnoid space of the rhesus monkey. J. Neurosurg. 42: 674-678.
27. 27. MEAKIN, S. O., AND E. M. SHOOTER. 1992. The nerve growth factor family of receptors. Trends Neurosci. 15: 323-331.
28. 28. MESULAM, M. M., E. J. MUFSON, A. I. LEVEY, AND B. H. WAINER. 1983. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia inominata), and hypothalamus in the rhesus monkey. J. Comp. Neurol. 214: 170-197.
29. 29. MESULAM, M. M., E. J. MUFSON, A. I. LEVEY, AND B. H. WAINER. 1984. Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyl-transferase immunohistochemistry and acetylcholinesterase histochemistry. Neuroscience 12: 669-686.
30. 30. MOBLEY, W. E., R. L. NEVE, R. H. EDWARDS, R. J. RIOPELLE, F. M. LONGO, G. WESKAMP, U. OTTEN, J. S. VALLETTA, AND M. V. JOHNSTON. 1989. Developmental regulation of nerve growth factor and its receptor in the caudate putamen. Neuron 3: 655-664.
31. 31. NRC. 1985. National Research Council. Guide for the care and use of laboratory animals. NIH Publication 85-23, Public Health Service, Washington, DC.
32. 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient. J. Neural Trans. 4: 79-95.
33. 33. PARDRIDGE, W. M. 1993. Transport of insulin-related peptides and glucose across the blood-brain barrier. Ann. N.Y. Acad. Sci. 692: 126-137.
34. 34. PARDRIDGE, W. M. 1991. Peptide drug delivery to the brain. Raven Press, New York, NY.
35. 35. RICHARDSON, P. M., V. M. VERGE-ISSA, AND R. J. RIOPELLE. 1986. Distribution of neuronal receptors for nerve growth factor in the rat. J. Neurosci. 6: 2312-2321.
36. 36. SAFFRAN, B. N. 1992. Should intracerebroventricular nerve growth factor be used to treat Alzheimer's disease? Perspect. Biol. Med. 35: 471-486.
37. 37. SCHATTEMAN, G. C., L. GIBBS, A. A. LANAHAN, P. CLAUDE, AND M. BOTHWELL. 1988. Expression of NGF receptor in the developing and adult primate brain. J. Neurosci. 8: 860-873.
38. 38. SCHWAB, M. E., U. OTTEN, A. AGID, AND H. THOENEN. 1979. Nerve growth factor (NGF) in the rat CNS: Absence of specific retrograde axonal transport and tyrosine hydroxylase induction in the locus coeruleus and substantia nigra. Brain Res. 168: 473-83.
39. 39. SCHWEITZER, J. B. 1987. Nerve growth factor receptor-mediated transport from cerebrospinal fluid to basal forebrain neurons. Brain Res. 423: 309-317.
40. 40. SCHWEITZER, J. B. 1989. Nerve growth factor receptor-mediated transport from CSF labels cholinergic neurons: Direct demonstration by a double-labelling study. Brain Res. 490: 390-396.
41. 41. SEILER, M., AND M. E. SCHWAB. 1984. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res. 300: 33-39.
42. 42. SZABO, J., AND W. M. COWAN. 1984. A stereotaxic atlas of the brain of the cynomolgus monkey (Macaca fascicularis). J. Comp. Neurol. 222: 265-300.
43. 43. THOENEN, H., C. BANDTLOW, AND R. HEUMANN. 1987. The physiological significance of nerve growth factor in the central nervous system: Comparison with the periphery. Rev. Physiol. Biochem. Pharmacol. 109: 146-178.
44. 44. TUSZYNSKI, M. H., U-H. SANG, D. G. AMARAL, AND F. H. GAGE. 1990. Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J. Neurosci. 10: 3604-3614.
45. 45. TUSZYNSKI, M. H., U. H. SANG, K. YOSHIDA, AND F. H. GAGE. 1991. Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain. Ann. Neurol. 30: 625-636.
46. 46. ULLRICH, A., A. GRAY, C. BERMAN, AND T. G. DULL. 1983. Human beta-nerve growth factor gene sequence highly homologous to that of mouse. Nature 303: 821-825.
47. 47. VAZQUEZ, M. E., AND T. EBENDAL. 1991. Messenger RNAs for trk and the low affinity receptor in the rat basal forebrain. Neuroreport 2: 593-596.
48. 48. VILLEGAS, J. C., AND R. D. BROADWELL. 1993. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. II. Adsorptive transcytosis of WGA-HRP and the blood-brain and brain-blood barriers. J. Neurocytol. 22: 67-80.
49. 49. WILL, B., AND F. HEFTI. 1985. Behavioural and neurochemical effects of chronic intraventricular injections of nerve growth factor in adults rats with fimbria lesions. Behav. Brain Res. 17: 17-24.
50. 50. WILLIAMS, L. R., S. VARON, G. M. PETERSON, K. WICTORIN, W. FISCHER, A. BJORKLUND, AND F. H. GAGE. 1986. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria-fornix transection. Proc. Natl. Acad. Sci. USA 87: 9231-9235.
51. 51. WILLIAMS, L. R., AND R. J. RYLETT. 1990. Exogenous nerve growth factor increases the activity of high-affinity choline uptake and choline acetyltransferase in brain of Fischer 344 males. J. Neurochem. 55: 1042-1049.
52. 52. YAN, Q., AND E. JOHNSON JR. 1989. Immunohistochemical localization and biochemical characterization of nerve growth factor (NGF) receptor in the adult brain. J. Comp. Neurol. 290: 585-598.
53. 53. YAN, Q., C. MATHESON, J. SUN, S. C. FEINSTEIN, AND J. A. MILLER. 1994. Distribution of intracerebral ventricularly administered neurotrophins in rat brain and its correlation with trk receptor expression. Exp. Neurol. 127: 23-36.